Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Accured Expenses (2020 - 2025)

Oncology Institute's Change in Accured Expenses history spans 6 years, with the latest figure at -$2.8 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 160.93% year-over-year to -$2.8 million; the TTM value through Dec 2025 reached -$448000.0, down 104.73%, while the annual FY2025 figure was -$448000.0, 104.73% down from the prior year.
  • Change in Accured Expenses reached -$2.8 million in Q4 2025 per TOI's latest filing, down from $127000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $5.4 million in Q1 2024 to a low of -$4.5 million in Q4 2021.
  • Average Change in Accured Expenses over 5 years is $582250.0, with a median of $345000.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: surged 5203.52% in 2021, then crashed 332.23% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at -$4.5 million in 2021, then skyrocketed by 87.93% to -$545000.0 in 2022, then surged by 609.72% to $2.8 million in 2023, then surged by 67.6% to $4.7 million in 2024, then plummeted by 160.93% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Change in Accured Expenses are -$2.8 million (Q4 2025), $127000.0 (Q3 2025), and -$305000.0 (Q2 2025).